Navigation
Market Outlook Stock Screener Dividend Calendar Event Calendar Rating of shares Markets News
Try free
Evelo Biosciences NASDAQ EVLO
$0.05 0.0000 0.0000%
Today share price
USA
Sector: Healthcare Industry: Biotechnology
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free
Rating Finrange Index: 21 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

869.21K
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
-1.20M
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.
1.49
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.
17.38M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.
-18.70 %
Upcoming events Evelo Biosciences All events
No upcoming events scheduled
Overview Financials Key Metrics Dividends Industry overview Events

Stock chart Evelo Biosciences

Stock analysis Evelo Biosciences

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

More
-0.01 13.20
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

More
-0.17 4.14
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

More
0.02 9.28
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

More
0.03 -0.09
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

More
308.34 9.25

Price change Evelo Biosciences per year

3.82$ 19.93$
Min Max

Summary analysis Evelo Biosciences

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Evelo Biosciences

Revenue and net income Evelo Biosciences

All parameters
Stock news Evelo Biosciences All news
28 October 2023 в 02:10

Evelo Biosciences, Horizon Technology Finance Sign Forbearance Agreement

28 October 2023 в 02:10

Evelo Biosciences, Horizon Technology Finance Sign Forbearance Agreement

17 October 2023 в 20:55

Evelo Biosciences Shares Down 58% After Unfavorable EDP2939 Results

17 October 2023 в 20:50

Evelo Biosciences Shares Down 58% After Unfavorable EDP2939 Results

17 October 2023 в 14:36

Evelo Biosciences to review options after Phase 2 trial of psoriasis treatment fails to meet main goal

17 October 2023 в 14:25

Evelo Biosciences Reviewing Alternatives After Study Didn't Meet Endpoint

17 October 2023 в 14:25

Evelo Biosciences Reviewing Alternatives After Study Didn't Meet Endpoint

10 July 2023 в 20:00

Evelo Biosciences Shares Rise 20% After Private Offering Prices

10 July 2023 в 19:55

Evelo Biosciences Shares Rise 20% After Private Offering Prices

26 April 2023 в 14:50

Evelo Biosciences Phase 2 Study Doesn't Meet Primary Endpoint

26 April 2023 в 14:50

Evelo Biosciences Phase 2 Study Doesn't Meet Primary Endpoint

11 August 2022 в 13:25

Evelo Biosciences President, CEO Gill to Transition to Chairman >EVLO

11 August 2022 в 13:25

Evelo Biosciences President, CEO Gill to Transition to Chairman >EVLO

18 July 2022 в 13:25

Evelo Biosciences Names Marella Thorell as CFO

18 July 2022 в 13:21

Evelo Biosciences Names Marella Thorell as CFO

24 March 2022 в 19:02

Evelo Biosciences Shares Rise 20% After Narrower-Than-Expected 4Q Loss

24 March 2022 в 19:02

Evelo Biosciences Shares Rise 20% After Narrower-Than-Expected 4Q Loss

8 February 2022 в 21:15

Evelo Biosciences Hits 52-Week Low for Second Consecutive Day

8 February 2022 в 21:15

Evelo Biosciences Hits 52-Week Low for Second Consecutive Day

7 February 2022 в 21:15

Evelo Biosciences Shares Hit 52-Week Low After Trial Results for Psoriasis Treatment

About company Evelo Biosciences

Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developing EDP1815, a whole-microbe candidate for the treatment of inflammatory diseases; and is in clinical development trial for the treatment of psoriasis and atopic dermatitis, as well as for the hyperinflammatory response associated with COVID-19. The company also engages in developing EDP1867, an inactivated investigational oral biologic for the treatment of inflammatory diseases; EDP2939, an extracellular vesicle investigational oral biologic for the treatment of inflammatory diseases; and EDP1908, a product candidate for oncology. Evelo Biosciences, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.
Address:
620 Memorial Drive, Cambridge, MA, United States, 02139
Company name: Evelo Biosciences
Issuer ticker: EVLO
ISIN: US2997341035
Country: USA
Exchange: NASDAQ
Currency: $
IPO date: 2018-05-09
Sector: Healthcare
Industry: Biotechnology
Site: https://www.evelobio.com

On which stock exchange are Evelo Biosciences (EVLO) stocks traded?

Evelo Biosciences (EVLO) stocks are traded on NASDAQ.

What is the ticker of Evelo Biosciences stocks (EVLO)?

The stock ticker of Evelo Biosciences’s stocks or in other words, the code is EVLO. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does Evelo Biosciences (EVLO) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Evelo Biosciences (EVLO) belongs to the «Healthcare» sector and the «Biotechnology» industry.

In what currency are Evelo Biosciences (EVLO) stocks traded?

Evelo Biosciences (EVLO) stocks are traded on the NASDAQ exchange in dollars.

What is the price of Evelo Biosciences (EVLO) stocks today?

The current price of Evelo Biosciences stocks on 28.04.2024 is 0.05 dollars. per share.

What is the dynamics of Evelo Biosciences (EVLO) stocks from the beginning of the year?

Evelo Biosciences (EVLO) quotes have increased by -7.06% from the beginning of the year up to 0.05 dollars. per 1 stocks.

How much did Evelo Biosciences (EVLO) stocks increase in апреле 2024?

This month Evelo Biosciences (EVLO) quotes have increased by 0% to 0.05 dollars. per share.

How much are Evelo Biosciences (EVLO) stocks worth?

Today, on October, 28.04.2024 Evelo Biosciences’s (EVLO) stocks cost 0.05 dollars..

What is the market capitalization of Evelo Biosciences (EVLO)?

Capitalization is the market value of Evelo Biosciences (EVLO) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 28.04.2024, the market capitalization of Evelo Biosciences (EVLO) is estimated at about 869212 dollars.